Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Bionow

  1. Events
  2. Organisers
  3. Bionow
Events from this organiser
Today

Biotech & Beers – Alderley Park

Biotech & Beers is an agenda-free networking evening offering professionals in the life sciences sector a relaxed space to connect over drinks. It’s a chance [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top